- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the NK Cell Therapy market will register a 16.8% CAGR in terms of revenue, the global market size will reach US$ 393.2 million by 2024, from US$ 211.5 million in 2019. In particular, this report presents the global revenue market share of key companies in NK Cell Therapy business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of NK Cell Therapy market by product type, application, key companies and key regions.
This study considers the NK Cell Therapy value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell agents took the largest market share segment, accounting for 82% and growing fastest
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cancer
Gastrointestinal Diseases
Others
Cancer was the most widely used area at 66%
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Nektar Therapeutics
Nkarta Therapeutics
Innate Pharma SA
Chipscreen Biosciences
Fate Therapeutics
Affimed
Kiadis Pharma
Glycostem Therapeutics
NantWorks
Dragonfly Therapeutics
Fortress Biotech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global NK Cell Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of NK Cell Therapy market by identifying its various subsegments.
Focuses on the key global NK Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the NK Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of NK Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
Global NK Cell Therapy Market Growth (Status and Outlook) 2019-2024
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NK Cell Therapy Market Size 2014-2024
2.1.2 NK Cell Therapy Market Size CAGR by Region
2.2 NK Cell Therapy Segment by Type
2.2.1 NK Cell Therapies
2.2.2 NK Cell Therapies
2.3 NK Cell Therapy Market Size by Type
2.3.1 Global NK Cell Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global NK Cell Therapy Market Size Growth Rate by Type (2014-2019)
2.4 NK Cell Therapy Segment by Application
2.4.1 Cancer
2.4.2 Gastrointestinal Diseases
2.4.3 Others
2.5 NK Cell Therapy Market Size by Application
2.5.1 Global NK Cell Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global NK Cell Therapy Market Size Growth Rate by Application (2014-2019)
3 Global NK Cell Therapy by Players
3.1 Global NK Cell Therapy Market Size Market Share by Players
3.1.1 Global NK Cell Therapy Market Size by Players (2017-2019)
3.1.2 Global NK Cell Therapy Market Size Market Share by Players (2017-2019)
3.2 Global NK Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NK Cell Therapy by Regions
4.1 NK Cell Therapy Market Size by Regions
4.2 Americas NK Cell Therapy Market Size Growth
4.3 APAC NK Cell Therapy Market Size Growth
4.4 Europe NK Cell Therapy Market Size Growth
4.5 Middle East & Africa NK Cell Therapy Market Size Growth
5 Americas
5.1 Americas NK Cell Therapy Market Size by Countries
5.2 Americas NK Cell Therapy Market Size by Type
5.3 Americas NK Cell Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC NK Cell Therapy Market Size by Countries
6.2 APAC NK Cell Therapy Market Size by Type
6.3 APAC NK Cell Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe NK Cell Therapy by Countries
7.2 Europe NK Cell Therapy Market Size by Type
7.3 Europe NK Cell Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa NK Cell Therapy by Countries
8.2 Middle East & Africa NK Cell Therapy Market Size by Type
8.3 Middle East & Africa NK Cell Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global NK Cell Therapy Market Forecast
10.1 Global NK Cell Therapy Market Size Forecast (2019-2024)
10.2 Global NK Cell Therapy Forecast by Regions
10.2.1 Global NK Cell Therapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global NK Cell Therapy Forecast by Type
10.8 Global NK Cell Therapy Forecast by Application
11 Key Players Analysis
11.1 Nektar Therapeutics
11.1.1 Company Details
11.1.2 NK Cell Therapy Product Offered
11.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Nektar Therapeutics News
11.2 Nkarta Therapeutics
11.2.1 Company Details
11.2.2 NK Cell Therapy Product Offered
11.2.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Nkarta Therapeutics News
11.3 Innate Pharma SA
11.3.1 Company Details
11.3.2 NK Cell Therapy Product Offered
11.3.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Innate Pharma SA News
11.4 Chipscreen Biosciences
11.4.1 Company Details
11.4.2 NK Cell Therapy Product Offered
11.4.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Chipscreen Biosciences News
11.5 Fate Therapeutics
11.5.1 Company Details
11.5.2 NK Cell Therapy Product Offered
11.5.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Fate Therapeutics News
11.6 Affimed
11.6.1 Company Details
11.6.2 NK Cell Therapy Product Offered
11.6.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Affimed News
11.7 Kiadis Pharma
11.7.1 Company Details
11.7.2 NK Cell Therapy Product Offered
11.7.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Kiadis Pharma News
11.8 Glycostem Therapeutics
11.8.1 Company Details
11.8.2 NK Cell Therapy Product Offered
11.8.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Glycostem Therapeutics News
11.9 NantWorks
11.9.1 Company Details
11.9.2 NK Cell Therapy Product Offered
11.9.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 NantWorks News
11.10 Dragonfly Therapeutics
11.10.1 Company Details
11.10.2 NK Cell Therapy Product Offered
11.10.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Dragonfly Therapeutics News
11.11 Fortress Biotech
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of NK Cell Therapy
Figure NK Cell Therapy Report Years Considered
Figure Market Research Methodology
Figure Global
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
